-
1
-
-
67349228410
-
The beta cell lesion in type 2 diabetes: There has to be a primary functional abnormality
-
Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009; 52: 1003-1012.
-
(2009)
Diabetologia
, vol.52
, pp. 1003-1012
-
-
Kahn, S.E.1
Zraika, S.2
Utzschneider, K.M.3
Hull, R.L.4
-
2
-
-
0034042959
-
Islet growth and development in the adult
-
Bonne r-Weir S. Islet growth and development in the adult. J Mol Endocrinol 2000; 24: 297-302.
-
(2000)
J Mol Endocrinol
, vol.24
, pp. 297-302
-
-
Bonner-Weir, S.1
-
3
-
-
33845881411
-
Mechanisms linking obesity to insulin resistance and type 2 diabetes
-
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846.
-
(2006)
Nature
, vol.444
, pp. 840-846
-
-
Kahn, S.E.1
Hull, R.L.2
Utzschneider, K.M.3
-
4
-
-
9444242665
-
Five stages of evolving beta-cell dysfunction during progression to diabetes
-
Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004; 53(Suppl 3): S16-S21.
-
(2004)
Diabetes
, vol.53
, Issue.SUPPL. 3
-
-
Weir, G.C.1
Bonner-Weir, S.2
-
5
-
-
33745863033
-
Islet beta cell failure in type 2 diabetes
-
Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006; 116: 1802-1812.
-
(2006)
J Clin Invest
, vol.116
, pp. 1802-1812
-
-
Prentki, M.1
Nolan, C.J.2
-
6
-
-
0842284799
-
Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes
-
Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53(Suppl 1): S119-S124.
-
(2004)
Diabetes
, vol.53
, Issue.SUPPL. 1
-
-
Robertson, R.P.1
Harmon, J.2
Tran, P.O.3
Poitout, V.4
-
8
-
-
0036895383
-
Endoplasmic reticulum stress and the development of diabetes: A review
-
Harding HP, Ron D. Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 2002; 51(Suppl 3): S455-S461.
-
(2002)
Diabetes
, vol.51
, Issue.SUPPL. 3
-
-
Harding, H.P.1
Ron, D.2
-
9
-
-
0037379714
-
Islet amyloid polypeptide and type 2 diabetes
-
Marzban L, Park K, Verchere CB. Islet amyloid polypeptide and type 2 diabetes. Exp Gerontol 2003; 38: 347-351.
-
(2003)
Exp Gerontol
, vol.38
, pp. 347-351
-
-
Marzban, L.1
Park, K.2
Verchere, C.B.3
-
10
-
-
79151478555
-
Type 2 diabetes as an inflammatory disease
-
Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
-
(2011)
Nat Rev Immunol
, vol.11
, pp. 98-107
-
-
Donath, M.Y.1
Shoelson, S.E.2
-
11
-
-
77952488104
-
Cytokine production by islets in health and diabetes: Cellular origin, regulation and function
-
Donath MY, Boni-Schnetzler M, Ellingsgaard H, Halban PA, Ehses JA. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol Metab 2010; 21: 261-267.
-
(2010)
Trends Endocrinol Metab
, vol.21
, pp. 261-267
-
-
Donath, M.Y.1
Boni-Schnetzler, M.2
Ellingsgaard, H.3
Halban, P.A.4
Ehses, J.A.5
-
12
-
-
69549098032
-
IL-1 antagon ism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
-
Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N et al. IL-1 antagon ism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci USA 2009; 106: 13998-14003.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 13998-14003
-
-
Ehses, J.A.1
Lacraz, G.2
Giroix, M.H.3
Schmidlin, F.4
Coulaud, J.5
Kassis, N.6
-
13
-
-
34548431826
-
Increased number of islet-associated macrophages in type 2 diabetes
-
Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-C ahn R et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007; 56: 2356-2370.
-
(2007)
Diabetes
, vol.56
, pp. 2356-2370
-
-
Ehses, J.A.1
Perren, A.2
Eppler, E.3
Ribaux, P.4
Pospisilik, J.A.5
Maor-Cahn, R.6
-
14
-
-
43549093332
-
Cytokines and beta-cell biology: From concept to clinical translation
-
Donath MY, Storling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 2008; 29: 334-350.
-
(2008)
Endocr Rev
, vol.29
, pp. 334-350
-
-
Donath, M.Y.1
Storling, J.2
Berchtold, L.A.3
Billestrup, N.4
Mandrup-Poulsen, T.5
-
15
-
-
11844297839
-
Type 1 database mellitus: An inflammatory disease of the islet
-
Bergholdt R, Heding P, Nielsen K, Nolsoe R, Sparre T, Storling J et al. Type 1 database mellitus: an inflammatory disease of the islet. Adv Exp Med Biol 2004; 552: 129-153.
-
(2004)
Adv Exp Med Biol
, vol.552
, pp. 129-153
-
-
Bergholdt, R.1
Heding, P.2
Nielsen, K.3
Nolsoe, R.4
Sparre, T.5
Storling, J.6
-
16
-
-
67649364114
-
The role of inflammation in insulitis and beta-cell loss in type 1 diabetes
-
Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009; 5: 219-226.
-
(2009)
Nat Rev Endocrinol
, vol.5
, pp. 219-226
-
-
Eizirik, D.L.1
Colli, M.L.2
Ortis, F.3
-
17
-
-
84878782369
-
Inflammation in obesity and diabetes: Islet dysfunction and therapeutic opportunity
-
Donath MY, Dalmas E, Sauter NS, Boni-Schnetzler M. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab 2013; 17: 860-872.
-
(2013)
Cell Metab
, vol.17
, pp. 860-872
-
-
Donath, M.Y.1
Dalmas, E.2
Sauter, N.S.3
Boni-Schnetzler, M.4
-
18
-
-
84897018309
-
Toll-like receptor 2/4 links to free fatty acidinduced inflammation and beta-cell dysfunction
-
Yin J Peng Y Wu J Wang Y Yao L Toll-like receptor 2/4 links to free fatty acidinduced inflammation and beta-cell dysfunction J Leukoc Biol 2013 95 47-52.
-
(2013)
J Leukoc Biol
, vol.95
, pp. 47-52
-
-
Yin, J.1
Peng, Y.2
Wu, J.3
Wang, Y.4
Yao, L.5
-
20
-
-
84879881087
-
Type 2 diabetes mellitus: A metabolic autoinflammatory disease
-
Mandrup-Poulsen T. Type 2 diabetes mellitus: a metabolic autoinflammatory disease. Dermatol Clin 2013; 31: 495-506.
-
(2013)
Dermatol Clin
, vol.31
, pp. 495-506
-
-
Mandrup-Poulsen, T.1
-
21
-
-
0036738398
-
Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets
-
Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002; 110: 851-860.
-
(2002)
J Clin Invest
, vol.110
, pp. 851-860
-
-
Maedler, K.1
Sergeev, P.2
Ris, F.3
Oberholzer, J.4
Joller-Jemelka, H.I.5
Spinas, G.A.6
-
22
-
-
33644669584
-
Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or th e type 2 diabetes milieu to human pancreatic islets
-
Welsh N, Cnop M, Kharroubi I, Bugliani M, Lupi R, Marchetti P et al. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or th e type 2 diabetes milieu to human pancreatic islets Diabetes 2005; 54: 3238-3244.
-
(2005)
Diabetes
, vol.54
, pp. 3238-3244
-
-
Welsh, N.1
Cnop, M.2
Kharroubi, I.3
Bugliani, M.4
Lupi, R.5
Marchetti, P.6
-
23
-
-
53749100698
-
Increased interleuki n (IL)-1beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation
-
Boni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses JA, Kerr-Conte J et al. Increased interleuki n (IL)-1beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab 2008; 93: 4065-4074.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 4065-4074
-
-
Boni-Schnetzler, M.1
Thorne, J.2
Parnaud, G.3
Marselli, L.4
Ehses, J.A.5
Kerr-Conte, J.6
-
24
-
-
75649096002
-
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
-
Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11: 136-140.
-
(2010)
Nat Immunol
, vol.11
, pp. 136-140
-
-
Zhou, R.1
Tardivel, A.2
Thorens, B.3
Choi, I.4
Tschopp, J.5
-
25
-
-
84883784100
-
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
-
Jourdan T, Godlewski G, Cinar R, Bertola A, Szanda G, Liu J et al. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med 2013; 19: 1132-1140.
-
(2013)
Nat Med
, vol.19
, pp. 1132-1140
-
-
Jourdan, T.1
Godlewski, G.2
Cinar, R.3
Bertola, A.4
Szanda, G.5
Liu, J.6
-
26
-
-
77955658618
-
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes
-
Igoillo-Esteve M, Marselli L, Cunha DA, Ladriere L, Ortis F, Grieco FA et al. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 2010; 53: 1395-1405.
-
(2010)
Diabetologia
, vol.53
, pp. 1395-1405
-
-
Igoillo-Esteve, M.1
Marselli, L.2
Cunha, D.A.3
Ladriere, L.4
Ortis, F.5
Grieco, F.A.6
-
27
-
-
71949118923
-
Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor i
-
Boni-Schnetzler M, Boller S, Debray S, Bouzakri K, Meier DT, Prazak R et al. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 2009; 150: 5218-5229.
-
(2009)
Endocrinology
, vol.150
, pp. 5218-5229
-
-
Boni-Schnetzler, M.1
Boller, S.2
Debray, S.3
Bouzakri, K.4
Meier, D.T.5
Prazak, R.6
-
28
-
-
84873693337
-
Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats
-
Akash MS, Rehman K, Sun H, Chen S. Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. Eur J Pharmacol 2013; 701: 87-95.
-
(2013)
Eur J Pharmacol
, vol.701
, pp. 87-95
-
-
Akash, M.S.1
Rehman, K.2
Sun, H.3
Chen, S.4
-
29
-
-
80054903245
-
Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage
-
Youm YH, Adijiang A, Vandanmagsar B, Burk D, Ravussin A, Dixit VD. Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology 2011; 152: 4039-4045.
-
(2011)
Endocrinology
, vol.152
, pp. 4039-4045
-
-
Youm, Y.H.1
Adijiang, A.2
Vandanmagsar, B.3
Burk, D.4
Ravussin, A.5
Dixit, V.D.6
-
30
-
-
84859449180
-
Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation
-
Eguchi K, Manabe I, Oishi-Tanaka Y, Ohsugi M, Kono N, Ogata F et al. Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation. Cell Metab 2012; 15: 518-533.
-
(2012)
Cell Metab
, vol.15
, pp. 518-533
-
-
Eguchi, K.1
Manabe, I.2
Oishi-Tanaka, Y.3
Ohsugi, M.4
Kono, N.5
Ogata, F.6
-
31
-
-
84878263657
-
Increased expression of Toll-like receptor and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes
-
Ladefoged M, Buschard K, Hansen AM. Increased expression of Toll-like receptor and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes. Apmis 2012; 121: 531-538.
-
(2012)
Apmis
, vol.121
, pp. 531-538
-
-
Ladefoged, M.1
Buschard, K.2
Hansen, A.M.3
-
32
-
-
84897019577
-
Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macroph age polarization
-
Cucak H, Grunnet LG, Rosendahl A. Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macroph age polarization. J Leukoc Biol 2013; 95: 149-160.
-
(2013)
J Leukoc Biol
, vol.95
, pp. 149-160
-
-
Cucak, H.1
Grunnet, L.G.2
Rosendahl, A.3
-
33
-
-
84876565085
-
Failure of the adaptive unfolded protein response in islets of obese mice is li nked with abnormalities in betacell gene expression and progression to diabetes
-
Chan JY, Luzuriaga J, Bensellam M, Biden TJ, Laybutt DR. Failure of the adaptive unfolded protein response in islets of obese mice is li nked with abnormalities in betacell gene expression and progression to diabetes. Diabetes 2013; 62: 1557-1568.
-
(2013)
Diabetes
, vol.62
, pp. 1557-1568
-
-
Chan, J.Y.1
Luzuriaga, J.2
Bensellam, M.3
Biden, T.J.4
Laybutt, D.R.5
-
34
-
-
77956958947
-
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes
-
Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA et a l. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 2010; 11: 897-904.
-
(2010)
Nat Immunol
, vol.11
, pp. 897-904
-
-
Masters, S.L.1
Dunne, A.2
Subramanian, S.L.3
Hull, R.L.4
Tannahill, G.M.5
Sharp, F.A.6
-
35
-
-
84894518230
-
Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1b production and beta cell dysfunction
-
(e-pub ahead of print 12 November; doi:10.2337/db13-0863
-
Westwell-Roper CY, Ehses JA, Ver chere CB. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1b production and beta cell dysfunction. Diabetes (e-pub ahead of print 12 November 2013; doi:10.2337/db13-0863).
-
(2013)
Diabetes
-
-
Westwell-Roper, C.Y.1
Ehses, J.A.2
Ver Chere, C.B.3
-
36
-
-
40749139988
-
Impaired glucose-stimulated insulin secretion is coupled with exocrine pancreatic lesions in the Cohen diabetic rat
-
Weksler-Zangen S, Ra z I, Lenzen S, Jorns A, Ehrenfeld S, Amir G et al. Impaired glucose-stimulated insulin secretion is coupled with exocrine pancreatic lesions in the Cohen diabetic rat. Diabetes 2008; 57: 279-287.
-
(2008)
Diabetes
, vol.57
, pp. 279-287
-
-
Weksler-Zangen, S.1
Ra, Z.I.2
Lenzen, S.3
Jorns, A.4
Ehrenfeld, S.5
Amir, G.6
-
37
-
-
33748306069
-
Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat
-
Homo-Delarche F, Calderari S, Irminger JC, Gangnerau MN, Coulaud J, Rickenbach K et al. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 2006; 55: 1625-1633.
-
(2006)
Diabetes
, vol.55
, pp. 1625-1633
-
-
Homo-Delarche, F.1
Calderari, S.2
Irminger, J.C.3
Gangnerau, M.N.4
Coulaud, J.5
Rickenbach, K.6
-
38
-
-
77952705847
-
Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains
-
Jones HB Nugent D Jenkins R Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains Int J Exp Pathol 2010 91 288-301.
-
(2010)
Int J Exp Pathol
, vol.91
, pp. 288-301
-
-
Jones, H.B.1
Nugent, D.2
Jenkins, R.3
-
39
-
-
79961045591
-
Excessive food intake, obesity and inflammation process in Zucker fa/fa rat pancreatic islets
-
Jones HB, Nugent D, Jenkins R. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains. Int J Exp Pathol 2010; 91: 288-301. 39 Chentouf M, Dubois G, Jahannaut C, Castex F, Lajoix AD, Gross R et al. Excessive food intake, obesity and inflammation process in Zucker fa/fa rat pancreatic islets. PLoS One 2011; 6: e22954.
-
(2011)
PLoS One
, vol.6
-
-
Chentouf, M.1
Dubois, G.2
Jahannaut, C.3
Castex, F.4
Lajoix, A.D.5
Gross, R.6
-
40
-
-
73349105599
-
Role of macrophages in the development of pancreatic islet injury in spontaneously diabetic torii rats
-
Inokuchi C, Ueda H, Hamaguchi T, Miyagawa J, Shinohara M, Okamura H et al. Role of macrophages in the development of pancreatic islet injury in spontaneously diabetic torii rats. Exp Ani m 2009; 58: 383-394.
-
(2009)
Exp Anim
, vol.58
, pp. 383-394
-
-
Inokuchi, C.1
Ueda, H.2
Hamaguchi, T.3
Miyagawa, J.4
Shinohara, M.5
Okamura, H.6
-
41
-
-
34247170807
-
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
-
Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356: 1517-1526.
-
(2007)
N Engl J Med
, vol.356
, pp. 1517-1526
-
-
Larsen, C.M.1
Faulenbach, M.2
Vaag, A.3
Volund, A.4
Ehses, J.A.5
Seifert, B.6
-
42
-
-
67650685521
-
Islet-associated macrophages in type 2 diabetes
-
Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. Islet-associated macrophages in type 2 diabetes. Diabetologia 2009; 52: 1686-1688.
-
(2009)
Diabetologia
, vol.52
, pp. 1686-1688
-
-
Richardson, S.J.1
Willcox, A.2
Bone, A.J.3
Foulis, A.K.4
Morgan, N.G.5
-
43
-
-
84871426151
-
Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes
-
Mahdi T, Hanzelmann S, Salehi A, Muhammed SJ, Reinbothe TM, Tang Y et al. Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab 2012; 16: 625-633.
-
(2012)
Cell Metab
, Issue.16
, pp. 625-633
-
-
Mahdi, T.1
Hanzelmann, S.2
Salehi, A.3
Muhammed, S.J.4
Reinbothe, T.M.5
Tang, Y.6
-
44
-
-
84894580064
-
Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes
-
(e-pub ahead of print 16 January; doi:10.1007/00125-013-3116-5
-
Butcher MJ, Hallinger D, Garcia E, Machida Y, Chakrabarti S, Nadler J et al. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia (e-pub ahead of print 16 January 2014; doi:10.1007/00125-013-3116-5).
-
(2014)
Diabetologia
-
-
Butcher, M.J.1
Hallinger, D.2
Garcia, E.3
Machida, Y.4
Chakrabarti, S.5
Nadler, J.6
-
45
-
-
84883505832
-
Beta-cell inflammation in h uman type 2 diabetes and the role of autophagy
-
Marselli L, Bugliani M, Suleiman M, Olimpico F, Masini M, Petrini M et al. Beta-cell inflammation in h uman type 2 diabetes and the role of autophagy. Diabetes Obes Metab 2013; 15(Suppl 3): 130-136.
-
(2013)
Diabetes Obes Metab
, vol.15
, Issue.SUPPL. 3
, pp. 130-136
-
-
Marselli, L.1
Bugliani, M.2
Suleiman, M.3
Olimpico, F.4
Masini, M.5
Petrini, M.6
-
46
-
-
84878774925
-
Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1beta antibody, in patients with type 2 diabetes
-
Sloan-Lancaster J, Abu-Raddad E, Polzer J, Miller JW, Scherer JC, De Gaetano A et al. Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1beta antibody, in patients with type 2 diabetes. Diabetes Care 2013; 36: 2239-2246.
-
(2013)
Diabetes Care
, vol.36
, pp. 2239-2246
-
-
Sloan-Lancaster, J.1
Abu-Raddad, E.2
Polzer, J.3
Miller, J.W.4
Scherer, J.C.5
De Gaetano, A.6
-
47
-
-
84864386088
-
Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes
-
Cavelti-Weder C, Babians-Brunner A, Keller C, Stahel MA, Kurz-Levin M, Zayed H et al. Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 2012; 35: 1654-1662.
-
(2012)
Diabetes Care
, vol.35
, pp. 1654-1662
-
-
Cavelti-Weder, C.1
Babians-Brunner, A.2
Keller, C.3
Stahel, M.A.4
Kurz-Levin, M.5
Zayed, H.6
-
48
-
-
84873271227
-
Effect of anti-IL-1beta antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: Results of a randomized, placebo-controll ed trial
-
Rissanen A, Howard CP, Botha J, Thuren T. Effect of anti-IL-1beta antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controll ed trial. Diabetes Obes Metab 2012; 14: 1088-1096.
-
(2012)
Diabetes Obes Metab
, vol.14
, pp. 1088-1096
-
-
Rissanen, A.1
Howard, C.P.2
Botha, J.3
Thuren, T.4
-
49
-
-
79960086288
-
Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: A randomized, double-blind, placebo-controlled study
-
van Asseldonk EJ, Stienstra R, Koenen TB, Joosten LA, Netea MG, Tack CJ. Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2011; 96: 2119-2126.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 2119-2126
-
-
Van Asseldonk, E.J.1
Stienstra, R.2
Koenen, T.B.3
Joosten, L.A.4
Netea, M.G.5
Tack, C.J.6
-
50
-
-
77950362382
-
The inflammasomes
-
Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832.
-
(2010)
Cell
, vol.140
, pp. 821-832
-
-
Schroder, K.1
Tschopp, J.2
-
51
-
-
0035524488
-
Toll-like receptors and innate immunity
-
Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
-
(2001)
Nat Rev Immunol
, vol.1
, pp. 135-145
-
-
Medzhitov, R.1
-
53
-
-
84865032889
-
New developments in Toll-like receptor targeted therapeutics
-
Connolly DJ, O'Neill LA. New developments in Toll-like receptor targeted therapeutics. Curr Opin Pharmacol 2012; 12: 510-518.
-
(2012)
Curr Opin Pharmacol
, vol.12
, pp. 510-518
-
-
Connolly, D.J.1
O'Neill, L.A.2
-
54
-
-
77953060025
-
Increased Toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects
-
Dasu MR, Devaraj S, Park S, Jialal I. Increased Toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010; 33: 861-868.
-
(2010)
Diabetes Care
, vol.33
, pp. 861-868
-
-
Dasu, M.R.1
Devaraj, S.2
Park, S.3
Jialal, I.4
-
55
-
-
34347399563
-
Metabolic endotoxemia initiates obesity and insulin resistance
-
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
-
(2007)
Diabetes
, vol.56
, pp. 1761-1772
-
-
Cani, P.D.1
Amar, J.2
Iglesias, M.A.3
Poggi, M.4
Knauf, C.5
Bastelica, D.6
-
56
-
-
33847040759
-
Increased intestinal permeability in obese mice: New evidence in the pathogenesis of nonalcoholic steatohepatitis
-
Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastroin test Liver Physiol 2007; 292: G518-G525.
-
(2007)
Am J Physiol Gastroin Test Liver Physiol
, vol.292
-
-
Brun, P.1
Castagliuolo, I.2
Di Leo, V.3
Buda, A.4
Pinzani, M.5
Palu, G.6
-
57
-
-
84877939137
-
Effect of lipopolysaccharide on inflammation and insulin action in human muscle
-
Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, Musi N. Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLoS One 2013; 8: e63983.
-
(2013)
PLoS One
, vol.8
-
-
Liang, H.1
Hussey, S.E.2
Sanchez-Avila, A.3
Tantiwong, P.4
Musi, N.5
-
58
-
-
33947182436
-
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes
-
Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292: E740-E747.
-
(2007)
Am J Physiol Endocrinol Metab
, vol.292
-
-
Creely, S.J.1
McTernan, P.G.2
Kusminski, C.M.3
Fisher, M.4
Da Silva, N.F.5
Khanolkar, M.6
-
59
-
-
1342302624
-
The effect of innate immunity on autoimmune diabetes and the expression of Tol l-like receptors on pancreatic islets
-
Wen L, Peng J, Li Z, Wong FS. The effect of innate immunity on autoimmune diabetes and the expression of Tol l-like receptors on pancreatic islets. J Immunol 2004; 172: 3173-3180.
-
(2004)
J Immunol
, vol.172
, pp. 3173-3180
-
-
Wen, L.1
Peng, J.2
Li, Z.3
Wong, F.S.4
-
60
-
-
85027953202
-
Involvement of the TLR4 (Toll-like receptor4) signali ng pathway in palmitate-induced INS-1 beta cell death
-
Lee SM Choi SE Lee JH Lee JJ Jung IR Lee SJ et al. Involvement of the TLR4 (Toll-like receptor4) signali ng pathway in palmitate-induced INS-1 beta cell death Mol Cell Biochem 2011 354 207-217.
-
(2011)
Mol Cell Biochem
, vol.354
, pp. 207-217
-
-
Lee, S.M.1
Choi, S.E.2
Lee, J.H.3
Lee, J.J.4
Jung, I.R.5
Lee, S.J.6
-
61
-
-
70349331508
-
Toll-like receptor agonist induced changes in clonal rat BRIN-BD11 beta-cell insulin secretion and signal transduction
-
Kiely A, Robinson A, McClenaghan NH, Flatt PR, Newsholme P. Toll-like receptor agonist induced changes in clonal rat BRIN-BD11 beta-cell insulin secretion and signal transduction. J Endocrinol 2009; 202: 365-373.
-
(2009)
J Endocrinol
, vol.202
, pp. 365-373
-
-
Kiely, A.1
Robinson, A.2
McClenaghan, N.H.3
Flatt, P.R.4
Newsholme, P.5
-
62
-
-
0043168062
-
Evidence of expression of endotoxin receptors CD14
-
Vives-Pi M, Somoza N, Fernandez-Alvarez J, Vargas F, Caro P, Alba A et al. Evidence of expression of endotoxin receptors CD14, Toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol 2003; 133: 208-218.
-
(2003)
Toll-like Receptors TLR4 and TLR2 and Associated Molecule MD-2 and of Sensitivity to Endotoxin (LPS) in Islet Beta Cells. Clin Exp Immunol
, vol.133
, pp. 208-218
-
-
Vives-Pi, M.1
Somoza, N.2
Fernandez-Alvarez, J.3
Vargas, F.4
Caro, P.5
Alba, A.6
-
63
-
-
79952044141
-
Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis
-
Garay-Malpartida HM, Mourao RF, Mantovani M, Santos IA, Sogayar MC, Goldberg AC. Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis. B MC Immunol 2011; 12: 18.
-
(2011)
B MC Immunol
, vol.12
, pp. 18
-
-
Garay-Malpartida, H.M.1
Mourao, R.F.2
Mantovani, M.3
Santos, I.A.4
Sogayar, M.C.5
Goldberg, A.C.6
-
64
-
-
78049480162
-
A subset of human pancreatic beta cells express functional CD14 receptors: A signal ing pathway for beta cell-related glycolipids, sulfatide and beta-galactosylceramide
-
Osterbye T, Funda DP, Fundova P, Mansson JE, Tlaskalova-Hogenova H, Buschard K. A subset of human pancreatic beta cells express functional CD14 receptors: a signal ing pathway for beta cell-related glycolipids, sulfatide and beta-galactosylceramide. Diabetes Metab Res Rev 2010; 26: 656-667.
-
(2010)
Diabetes Metab Res Rev
, vol.26
, pp. 656-667
-
-
Osterbye, T.1
Funda, D.P.2
Fundova, P.3
Mansson, J.E.4
Tlaskalova-Hogenova, H.5
Buschard, K.6
-
65
-
-
58749093419
-
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling
-
Schulthess FT, Paroni F, Sauter NS, Shu L, Ribaux P, Haataja L et al. CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab 2009; 9: 125-139.
-
(2009)
Cell Metab
, vol.9
, pp. 125-139
-
-
Schulthess, F.T.1
Paroni, F.2
Sauter, N.S.3
Shu, L.4
Ribaux, P.5
Haataja, L.6
-
66
-
-
77955492173
-
Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet
-
Ehses JA, Meier DT, Wueest S, Rytka J, Boller S, Wielinga PY et al. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia 2010; 53: 1795-1806.
-
(2010)
Diabetologia
, vol.53
, pp. 1795-1806
-
-
Ehses, J.A.1
Meier, D.T.2
Wueest, S.3
Rytka, J.4
Boller, S.5
Wielinga, P.Y.6
-
67
-
-
84860485809
-
Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-Like Receptor-4 and NF-kappaB signalling
-
Amyot J, Semache M, Ferdaoussi M, Fontes G, Poitout V. Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-Like Receptor-4 and NF-kappaB signalling. PLoS One 2012; 7: e36200.
-
(2012)
PLoS One
, vol.7
-
-
Amyot, J.1
Semache, M.2
Ferdaoussi, M.3
Fontes, G.4
Poitout, V.5
-
68
-
-
77949756774
-
Highmobility group box 1 is involved in the initial events of early loss of transplanted islets in mice
-
Matsuoka N, Itoh T, Watarai H, Sekine-Kondo E, Nagata N, Okamoto K et al. Highmobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. J Clin Invest 2010; 120: 735-743.
-
(2010)
J Clin Invest
, vol.120
, pp. 735-743
-
-
Matsuoka, N.1
Itoh, T.2
Watarai, H.3
Sekine-Kondo, E.4
Nagata, N.5
Okamoto, K.6
-
69
-
-
34548036686
-
Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes
-
Kim HS, Han MS, Chung KW, Kim S, Kim E, Kim MJ et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. I mmunity 2007; 27: 321-333.
-
(2007)
Immunity
, vol.27
, pp. 321-333
-
-
Kim, H.S.1
Han, M.S.2
Chung, K.W.3
Kim, S.4
Kim, E.5
Kim, M.J.6
-
70
-
-
80051842679
-
Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement
-
Lecube A, Pachon G, Petriz J, Hernandez C, Simo R. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One 2011; 6: e23366.
-
(2011)
PLoS One
, vol.6
-
-
Lecube, A.1
Pachon, G.2
Petriz, J.3
Hernandez, C.4
Simo, R.5
-
71
-
-
33644843857
-
Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1
-
Steer SA, Scarim AL, Chambers KT, Corbett JA. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med 2006; 3: e17.
-
(2006)
PLoS Med
, vol.3
-
-
Steer, S.A.1
Scarim, A.L.2
Chambers, K.T.3
Corbett, J.A.4
-
72
-
-
80052278497
-
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: Molecular mechanisms and probiotic treatment
-
Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermudez-Humaran LG et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011; 3: 559-572.
-
(2011)
EMBO Mol Med
, vol.3
, pp. 559-572
-
-
Amar, J.1
Chabo, C.2
Waget, A.3
Klopp, P.4
Vachoux, C.5
Bermudez-Humaran, L.G.6
-
73
-
-
84899431671
-
Activation of Toll-like receptor by islet amyloid polypeptide: A trigger for islet inflammation in type 2 diabetes
-
Westwell-Roper C, Ehses JA, Verchere CB. Activation of Toll-like receptor by islet amyloid polypeptide: a trigger for islet inflammation in type 2 diabetes Can J Diabetes 2012; 36: S18.
-
(2012)
Can J Diabetes
, vol.36
-
-
Westwell-Roper, C.1
Ehses, J.A.2
Verchere, C.B.3
-
74
-
-
77954005130
-
Endogenous ligands of TLR2 and TLR4 agonists or assistants
-
Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants J Leukoc Biol 2010; 87: 989-999.
-
(2010)
J Leukoc Biol
, vol.87
, pp. 989-999
-
-
Erridge, C.1
-
76
-
-
84864693470
-
Thiored oxin-interacting protein mediates ER stress-induced beta cell death through initiation of the inflammasome
-
Oslowski CM, Hara T, O'Sullivan-Murphy B, Kanekura K, Lu S, Hara M et al. Thiored oxin-interacting protein mediates ER stress-induced beta cell death through initiation of the inflammasome. Cell Metab 2012; 16: 265-273.
-
(2012)
Cell Metab
, vol.16
, pp. 265-273
-
-
Oslowski, C.M.1
Hara, T.2
O'Sullivan-Murphy, B.3
Kanekura, K.4
Lu, S.5
Hara, M.6
-
77
-
-
35548930371
-
Induction of CXCL1 by extracellular matrix and autocrine enhancement by IL-1 in rat pancreatic { beta}-cells
-
Ribaux P, Ehses JA, Lin-Marq N, Carrozzino F, Boni-Schnetzler M, Hammar E et al. Induction of CXCL1 by extracellular matrix and autocrine enhancement by IL-1 in rat pancreatic { beta}-cells. Endocrinology 2007; 148: 5582-5590.
-
(2007)
Endocrinology
, vol.148
, pp. 5582-5590
-
-
Ribaux, P.1
Ehses, J.A.2
Lin-Marq, N.3
Carrozzino, F.4
Boni-Schnetzler, M.5
Hammar, E.6
-
78
-
-
84878263657
-
Increased expression of Toll-like receptor and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes
-
Ladefoged M, Buschar d K, Hansen AM. Increased expression of Toll-like receptor and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes. APMIS 2013; 121: 531-538.
-
(2013)
APMIS
, vol.121
, pp. 531-538
-
-
Ladefoged, M.1
Buschard, K.2
Hansen, A.M.3
-
80
-
-
78651383854
-
Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancre atic islet endocrine cells
-
Lawrence MC, Naziruddin B, Levy MF, Jackson A, McGlynn K. Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancre atic islet endocrine cells. J Biol Chem 2011; 286: 1025-1036.
-
(2011)
J Biol Chem
, vol.286
, pp. 1025-1036
-
-
Lawrence, M.C.1
Naziruddin, B.2
Levy, M.F.3
Jackson, A.4
McGlynn, K.5
-
81
-
-
67650485985
-
Alternative activation of macrophages: An immunologic functional perspective
-
Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
-
(2009)
Annu Rev Immunol
, vol.27
, pp. 451-483
-
-
Martinez, F.O.1
Helming, L.2
Gordon, S.3
-
82
-
-
56749174940
-
Exploring the full spectrum of macrophage activation
-
Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
-
(2008)
Nat Rev Immunol
, vol.8
, pp. 958-969
-
-
Mosser, D.M.1
Edwards, J.P.2
-
83
-
-
77956976681
-
Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm
-
Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11: 889-896.
-
(2010)
Nat Immunol
, vol.11
, pp. 889-896
-
-
Biswas, S.K.1
Mantovani, A.2
-
84
-
-
79955693448
-
The inflammasome in atherosclerosis and type 2 diabetes
-
Masters SL, Latz E, O'Neill LA. The inflammasome in atherosclerosis and type 2 diabetes. Sci Transl Med 2011; 3: 81ps17.
-
(2011)
Sci Transl Med
, vol.3
-
-
Masters, S.L.1
Latz, E.2
O'Neill, L.A.3
-
85
-
-
84867770402
-
Nontranscriptional primin g and deubiquitination regulate NLRP3 inflammasome activation
-
Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F, Alnemri ES. Nontranscriptional primin g and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem 2012; 287: 36617-36622.
-
(2012)
J Biol Chem
, vol.287
, pp. 36617-36622
-
-
Juliana, C.1
Fernandes-Alnemri, T.2
Kang, S.3
Farias, A.4
Qin, F.5
Alnemri, E.S.6
-
86
-
-
84887897805
-
Phosp horylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity
-
Hara H, Tsuchiya K, Kawamura I, Fang R, Hernandez-Cuellar E, Shen Y et al. Phosp horylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat Immunol 2013; 14: 1247-1255.
-
(2013)
Nat Immunol
, vol.14
, pp. 1247-1255
-
-
Hara, H.1
Tsuchiya, K.2
Kawamura, I.3
Fang, R.4
Hernandez-Cuellar, E.5
Shen, Y.6
-
87
-
-
2342435824
-
Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1
-
Lee JY, Zhao L, Youn HS, W eatherill AR, Tapping R, Feng L et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004; 279: 16971-16979.
-
(2004)
J Biol Chem
, vol.279
, pp. 16971-16979
-
-
Lee, J.Y.1
Zhao, L.2
Youn, H.S.3
Eatherill, A.R.W.4
Tapping, R.5
Feng, L.6
-
88
-
-
84864829032
-
Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways
-
Huang S, Rutkowsky JM, Snodgrass RG, Ono-Moore KD, Schneider DA, Newman JW et al. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res 2012; 53: 2002-2013.
-
(2012)
J Lipid Res
, vol.53
, pp. 2002-2013
-
-
Huang, S.1
Rutkowsky, J.M.2
Snodgrass, R.G.3
Ono-Moore, K.D.4
Schneider, D.A.5
Newman, J.W.6
-
89
-
-
43149125857
-
Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules
-
Calderon B, Suri A, Miller MJ, Unanue ER. Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proc Natl Acad Sci USA 2008 ; 105: 6121-6126.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 6121-6126
-
-
Calderon, B.1
Suri, A.2
Miller, M.J.3
Unanue, E.R.4
-
90
-
-
84872018875
-
Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes
-
Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 2013; 62: 194-204.
-
(2013)
Diabetes
, vol.62
, pp. 194-204
-
-
Lee, H.M.1
Kim, J.J.2
Kim, H.J.3
Shong, M.4
Ku, B.J.5
Jo, E.K.6
-
91
-
-
84875369124
-
Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4
-
Liang CF, Liu JT, Wang Y, Xu A, Vanhoutte PM. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arterioscler Thromb Vasc Biol 2013; 33: 777-784.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 777-784
-
-
Liang, C.F.1
Liu, J.T.2
Wang, Y.3
Xu, A.4
Vanhoutte, P.M.5
-
92
-
-
84855174006
-
Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice
-
Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Bi ol 2011; 9: e1001212.
-
(2011)
PLoS Bi Ol
, vol.9
-
-
Caricilli, A.M.1
Picardi, P.K.2
De Abreu, L.L.3
Ueno, M.4
Prada, P.O.5
Ropelle, E.R.6
-
93
-
-
84866461477
-
Familial transmission rather than defective innate immunity shapes the distinct intestinal micr obiota of TLR-deficient mice
-
Ubeda C, Lipuma L, Gobourne A, Viale A, Leiner I, Equinda M et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal micr obiota of TLR-deficient mice. J Exp Med 2012; 209: 1445-1456.
-
(2012)
J Exp Med
, vol.209
, pp. 1445-1456
-
-
Ubeda, C.1
Lipuma, L.2
Gobourne, A.3
Viale, A.4
Leiner, I.5
Equinda, M.6
-
94
-
-
80052650475
-
IL-1 blockade attenuates islet am yloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction
-
Westwell-Roper C, Dai DL, Soukhatcheva G, Potter KJ, van Rooijen N, Ehses JA et al. IL-1 blockade attenuates islet am yloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 2011; 187: 2755-2765.
-
(2011)
J Immunol
, vol.187
, pp. 2755-2765
-
-
Westwell-Roper, C.1
Dai, D.L.2
Soukhatcheva, G.3
Potter, K.J.4
Van Rooijen, N.5
Ehses, J.A.6
-
95
-
-
0023174987
-
Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity
-
Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen JH, Dinarello CA. Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand C 1987; 95: 55-63.
-
(1987)
Acta Pathol Microbiol Immunol Scand C
, vol.95
, pp. 55-63
-
-
Mandrup-Poulsen, T.1
Egeberg, J.2
Nerup, J.3
Bendtzen, K.4
Nielsen, J.H.5
Dinarello, C.A.6
-
96
-
-
0022445268
-
Cytotoxicity of human pI interleukin-1 for pancreatic islets of Langerhans
-
Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545-1547.
-
(1986)
Science
, vol.232
, pp. 1545-1547
-
-
Bendtzen, K.1
Mandrup-Poulsen, T.2
Nerup, J.3
Nielsen, J.H.4
Dinarello, C.A.5
Svenson, M.6
-
97
-
-
0023261567
-
Interleukin dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans
-
Spinas GA, Hansen BS, Linde S, Kastern W, Molvig J, Mandrup-Poulsen T et al. Interleukin dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia 1987; 30: 474-480.
-
(1987)
Diabetologia
, vol.30
, pp. 474-480
-
-
Spinas, G.A.1
Hansen, B.S.2
Linde, S.3
Kastern, W.4
Molvig, J.5
Mandrup-Poulsen, T.6
-
98
-
-
0031710647
-
Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase
-
Wadt KA, Larsen CM, Andersen HU, Nielsen K, Karlsen AE, Mandrup-Poulsen T. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase. Diabetes 1998; 47: 1602-1608.
-
(1998)
Diabetes
, vol.47
, pp. 1602-1608
-
-
Wadt, K.A.1
Larsen, C.M.2
Andersen, H.U.3
Nielsen, K.4
Karlsen, A.E.5
Mandrup-Poulsen, T.6
-
100
-
-
0023601773
-
Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity
-
Mandrup-Poulsen T, Bend tzen K, Dinarello CA, Nerup J. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J Immunol 1987; 139: 4077-4082
-
(1987)
J Immunol
, vol.139
, pp. 4077-4082
-
-
Mandrup-Poulsen, T.1
Bendtzen, K.2
Dinarello, C.A.3
Nerup, J.4
-
101
-
-
0023768414
-
Interleukin-1 induced impairment in pancreatic islet oxidative metab o lism of glucose is potentiated by tumor necrosis factor
-
Eizirik DL. Interleukin-1 induced impairment in pancreatic islet oxidative metab o lism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol 1988; 119: 321-325.
-
(1988)
Acta Endocrinol
, vol.119
, pp. 321-325
-
-
Eizirik, D.L.1
-
102
-
-
0025685395
-
Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric o x ide generating mechanism
-
Southern C, Schulster D, Green IC. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric o x ide generating mechanism. FEBS Lett 1990; 276: 42-44.
-
(1990)
FEBS Lett
, vol.276
, pp. 42-44
-
-
Southern, C.1
Schulster, D.2
Green, I.C.3
-
103
-
-
42449091550
-
The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia
-
Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K. The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 2008 149: 2208-2218.
-
(2008)
Endocrinology
, vol.149
, pp. 2208-2218
-
-
Sauter, N.S.1
Schulthess, F.T.2
Galasso, R.3
Castellani, L.W.4
Maedler, K.5
-
104
-
-
84881048861
-
Endoplasmic reticulum stress sensitizes pancreatic beta cells to interleukin-1beta-induced apoptosis via Bim/A1 imbalance
-
Miani M, Barthson J, Colli ML, Brozzi F, Cnop M, Eizirik DL. Endoplasmic reticulum stress sensitizes pancreatic beta cells to interleukin-1beta-induced apoptosis via Bim/A1 imbalance. Cell Death Dis 2013; 4: e701.
-
(2013)
Cell Death Dis
, vol.4
-
-
Miani, M.1
Barthson, J.2
Colli, M.L.3
Brozzi, F.4
Cnop, M.5
Eizirik, D.L.6
-
105
-
-
84883159268
-
Circulating levels of IL-1B+ IL-6 cause ER stress and dysfunction in islets from prediabetic male mice
-
O'Neill CM, Lu C, Corbin KL, Sharma PR, Dula SB, Carter JD et al. Circulating levels of IL-1B+ IL-6 cause ER stress and dysfunction in islets from prediabetic male mice. Endocrinology 2013; 154: 3077-3088.
-
(2013)
Endocrinology
, vol.154
, pp. 3077-3088
-
-
O'Neill, C.M.1
Lu, C.2
Corbin, K.L.3
Sharma, P.R.4
Dula, S.B.5
Carter, J.D.6
-
106
-
-
0024406719
-
Evidence for IL-6 pr oduction by and effects on the pancreatic beta-cell
-
Campbell IL, Cutri A, Wilson A, Harrison LC. Evidence for IL-6 pr oduction by and effects on the pancreatic beta-cell. J Immunol 1989; 143: 1188-1191.
-
(1989)
J Immunol
, vol.143
, pp. 1188-1191
-
-
Campbell, I.L.1
Cutri, A.2
Wilson, A.3
Harrison, L.C.4
-
107
-
-
79551584783
-
Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: Potential invol v ement of the PLC-IP3-dependent pathway
-
Suzuki T, Imai J, Yamada T, Ishigaki Y, Kaneko K, Uno K et al. Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential invol v ement of the PLC-IP3-dependent pathway. Diabetes 2011; 60: 537-547.
-
(2011)
Diabetes
, vol.60
, pp. 537-547
-
-
Suzuki, T.1
Imai, J.2
Yamada, T.3
Ishigaki, Y.4
Kaneko, K.5
Uno, K.6
-
108
-
-
0029417040
-
Interleukin-1 beta induces the expression of hsp70, heme oxygenase and Mn-SOD in FACS-purified rat islet betacells, but not in alpha-cells
-
Strandell E, Buschard K, Saldeen J, Welsh N. Interleukin-1 beta induces the expression of hsp70, heme oxygenase and Mn-SOD in FACS-purified rat islet betacells, but not in alpha-cells . Immunol Lett 1995; 48: 145-148.
-
(1995)
Immunol Lett
, vol.48
, pp. 145-148
-
-
Strandell, E.1
Buschard, K.2
Saldeen, J.3
Welsh, N.4
-
109
-
-
0025269469
-
Comparison of cytokine effects on mouse pancreatic alpha-cell and beta-cell lines. Viability, secretory function, and MHC antigen expression
-
Hamaguchi K, Leiter EH. Comparison of cytokine effects on mouse pancreatic alpha-cell and beta-cell lines. Viability, secretory function, and MHC antigen expression. Diabetes 1990; 39: 415-425.
-
(1990)
Diabetes
, vol.39
, pp. 415-425
-
-
Hamaguchi, K.1
Leiter, E.H.2
-
110
-
-
0023899820
-
Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures
-
Rabinovitch A, Pukel C, Baquerizo H. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures. Endocrinology 1988; 122: 2393-2398.
-
(1988)
Endocrinology
, vol.122
, pp. 2393-2398
-
-
Rabinovitch, A.1
Pukel, C.2
Baquerizo, H.3
-
111
-
-
34250854205
-
The role of alpha-cell dysregulation in fasting and postprandial hyperg l ycemia in type2 diabetes and therapeutic implications
-
Dunning BE, Gerich JE. The role of alpha-cell dysregulation in fasting and postprandial hyperg l ycemia in type2 diabetes and therapeutic implications. Endocr Rev 2007; 28: 253-283.
-
(2007)
Endocr Rev
, vol.28
, pp. 253-283
-
-
Dunning, B.E.1
Gerich, J.E.2
-
112
-
-
0034524938
-
Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mell i tus
-
Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mell i tus. J Clin Endocrinol Metab 2000; 85: 4053-4059.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 4053-4059
-
-
Shah, P.1
Vella, A.2
Basu, A.3
Basu, R.4
Schwenk, W.F.5
Rizza, R.A.6
-
114
-
-
0345700727
-
Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study
-
Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003; 52: 812-817.
-
(2003)
Diabetes
, vol.52
, pp. 812-817
-
-
Spranger, J.1
Kroke, A.2
Mohlig, M.3
Hoffmann, K.4
Bergmann, M.M.5
Ristow, M.6
-
115
-
-
33644755633
-
Interleukin-6 and diabetes: The good, the bad, or the indifferent
-
Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent Diabetes 2005; 54(Suppl 2): S114-S124.
-
(2005)
Diabetes
, vol.54
, Issue.SUPPL. 2
-
-
Kristiansen, O.P.1
Mandrup-Poulsen, T.2
-
116
-
-
84860764263
-
Impaired crosstalk between pu l satile insulin and glucagon secretion in prediabetic individuals
-
Rohrer S, Menge BA, Gruber L, Deacon CF, Schmidt WE, Veldhuis JD et al. Impaired crosstalk between pu l satile insulin and glucagon secretion in prediabetic individuals. J Clin Endocrinol Metab 2012; 97: E791-E795.
-
(2012)
J Clin Endocrinol Metab
, vol.97
-
-
Rohrer, S.1
Menge, B.A.2
Gruber, L.3
Deacon, C.F.4
Schmidt, W.E.5
Veldhuis, J.D.6
-
117
-
-
77953939472
-
Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction
-
Kawamori D, Welters HJ, Kulkarni RN. Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction. Adv Exp Med Biol 2010; 654: 421-445.
-
(2010)
Adv Exp Med Biol
, vol.654
, pp. 421-445
-
-
Kawamori, D.1
Welters, H.J.2
Kulkarni, R.N.3
-
118
-
-
81255157471
-
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
-
Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 2011; 17: 1481-1489.
-
(2011)
Nat Med
, vol.17
, pp. 1481-1489
-
-
Ellingsgaard, H.1
Hauselmann, I.2
Schuler, B.3
Habib, A.M.4
Baggio, L.L.5
Meier, D.T.6
-
120
-
-
84855481978
-
Toll-like receptors and diabetes: A therapeutic perspective
-
Dasu MR, Ramirez S, Isseroff RR. Toll-like receptors and diabetes: a therapeutic perspective. Clin Sci (Lond) 2012; 122: 203-214.
-
(2012)
Clin Sci (Lond)
, vol.122
, pp. 203-214
-
-
Dasu, M.R.1
Ramirez, S.2
Isseroff, R.R.3
-
121
-
-
84886725015
-
Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous opn-305, a humanized anti-tlr2 antibody
-
Reilly M, Miller RM, Thomson MH, Patris V, Ryle P, McLoughlin L et al. Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous opn-305, a humanized anti-tlr2 antibody. Clin Pharmacol Ther 2013; 94 593-600.
-
(2013)
Clin Pharmacol Ther
, vol.94
, pp. 593-600
-
-
Reilly, M.1
Miller, R.M.2
Thomson, M.H.3
Patris, V.4
Ryle, P.5
McLoughlin, L.6
-
122
-
-
84870546138
-
Discovery of small-molecule inhibitors of the TLR1/TLR2 complex
-
Cheng K, Wang X, Zhang S, Yin H. Discovery of small-molecule inhibitors of the TLR1/TLR2 complex. Angew Chem Int Ed Engl 2012; 51: 12246-12249.
-
(2012)
Angew Chem Int Ed Engl
, vol.51
, pp. 12246-12249
-
-
Cheng, K.1
Wang, X.2
Zhang, S.3
Yin, H.4
-
123
-
-
70349342913
-
Identification and characterization of oligonucle o tides that inhibit Toll-like receptor 2-associated immune responses
-
Chang YC, Kao WC, Wang WY, Yang RB, Peck K. Identification and characterization of oligonucle o tides that inhibit Toll-like receptor 2-associated immune responses FASEB J 2009; 23: 3078-3088.
-
(2009)
FASEB J
, vol.23
, pp. 3078-3088
-
-
Chang, Y.C.1
Kao, W.C.2
Wang, W.Y.3
Yang, R.B.4
Peck, K.5
-
124
-
-
84875124740
-
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with se v ere sepsis: The ACCESS randomized trial
-
Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with se v ere sepsis: the ACCESS randomized trial. JAMA 2013; 309: 1154-1162.
-
(2013)
JAMA
, vol.309
, pp. 1154-1162
-
-
Opal, S.M.1
Laterre, P.F.2
Francois, B.3
Larosa, S.P.4
Angus, D.C.5
Mira, J.P.6
-
125
-
-
77954953617
-
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis
-
Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Me d 2010; 38 1685-1694.
-
(2010)
Crit Care Med
, vol.38
, pp. 1685-1694
-
-
Rice, T.W.1
Wheeler, A.P.2
Bernard, G.R.3
Vincent, J.L.4
Angus, D.C.5
Aikawa, N.6
-
126
-
-
78651300299
-
TAK-242 (resatorvid), a smallmolecule inhibitor of Toll-like receptor (TLR) signaling, binds selectively to TLR4 and interferes with interactions between TL R4 and its adaptor molecules
-
Matsunaga N, Tsuchimori N, Matsumoto T, Ii M. TAK-242 (resatorvid), a smallmolecule inhibitor of Toll-like receptor (TLR) signaling, binds selectively to TLR4 and interferes with interactions between TL R4 and its adaptor molecules. Mol Pharmacol 2011 79: 34-41.
-
(2011)
Mol Pharmacol
, vol.79
, pp. 34-41
-
-
Matsunaga, N.1
Tsuchimori, N.2
Matsumoto, T.3
Ii, M.4
-
127
-
-
84877048917
-
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy
-
Lin M, Yiu WH, Li RX, Wu HJ, Wong DW, Chan LY et al. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int 2013 83 887-900.
-
(2013)
Kidney Int
, vol.83
, pp. 887-900
-
-
Lin, M.1
Yiu, W.H.2
Li, R.X.3
Wu, H.J.4
Wong, D.W.5
Chan, L.Y.6
-
128
-
-
78651300299
-
Renal protective effects of Toll-like receptor signaling, binds selectively to TLR4 and interferes with interactions between TL R4 and its adaptor molecules
-
Cha JJ, Hy un YY, Lee MH, Kim JE, Nam DH, Song HK et al. Renal protective effects of Toll-like receptor signaling, binds selectively to TLR4 and interferes with interactions between TL R4 and its adaptor molecules. Mol Pharmacol 2011; 79: 34-41.
-
(2011)
Mol Pharmacol
, vol.79
, pp. 34-41
-
-
Cha, J.J.1
Hyun, Y.Y.2
Lee, M.H.3
Kim, J.E.4
Nam, D.H.5
Song, H.K.6
-
129
-
-
84055182560
-
The cytokine release i nhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes
-
Coll RC, O'Neill LA. The cytokine release i nhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS One 2011; 6: e29539.
-
(2011)
PLoS One
, vol.6
-
-
Coll, R.C.1
O'Neill, L.A.2
-
130
-
-
34249907880
-
Macrophage PPAR gamma is required for normal skeletal muscl e and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones
-
Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY et al. Macrophage PPAR gamma is required for normal skeletal muscl e and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest 2007; 117: 1658-1669.
-
(2007)
J Clin Invest
, vol.117
, pp. 1658-1669
-
-
Hevener, A.L.1
Olefsky, J.M.2
Reichart, D.3
Nguyen, M.T.4
Bandyopadyhay, G.5
Leung, H.Y.6
-
131
-
-
79251541159
-
Dipeptidyl peptidase IV inhibitor sitagliptin reduces local infl ammation in adipose tissue and in pancreatic islets of obese mice
-
Dobrian AD, Ma Q, Lindsay JW, Leone KA, Ma K, Coben J et al. Dipeptidyl peptidase IV inhibitor sitagliptin reduces local infl ammation in adipose tissue and in pancreatic islets of obese mice. Am J Physiol Endocrinol Metab 2011; 300 E410-E421
-
(2011)
Am J Physiol Endocrinol Metab
, vol.300
-
-
Dobrian, A.D.1
Ma, Q.2
Lindsay, J.W.3
Leone, K.A.4
Ma, K.5
Coben, J.6
|